| __timestamp | ADMA Biologics, Inc. | Amicus Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 47624000 |
| Thursday, January 1, 2015 | 7015946 | 76943000 |
| Friday, January 1, 2016 | 7688238 | 104793000 |
| Sunday, January 1, 2017 | 6229587 | 149310000 |
| Monday, January 1, 2018 | 3926120 | 270902000 |
| Tuesday, January 1, 2019 | 2343848 | 286378000 |
| Wednesday, January 1, 2020 | 5907013 | 308443000 |
| Friday, January 1, 2021 | 3646060 | 272049000 |
| Saturday, January 1, 2022 | 3613764 | 276677000 |
| Sunday, January 1, 2023 | 3300000 | 152381000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ADMA Biologics, Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Amicus Therapeutics consistently outspent ADMA Biologics, with its R&D expenses peaking at over 300% higher than ADMA's in 2020. This significant investment reflects Amicus's aggressive strategy to advance its therapeutic pipeline. Meanwhile, ADMA Biologics maintained a more conservative R&D budget, with a notable decrease of approximately 65% from 2014 to 2023. This divergence in spending highlights the varied strategies within the biotech sector, where some companies prioritize rapid innovation, while others focus on sustainable growth. As the industry evolves, these spending patterns may offer insights into future breakthroughs and market leadership.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Gilead Sciences, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Amicus Therapeutics, Inc.
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Axsome Therapeutics, Inc. or ADMA Biologics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.